Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Leishmaniasis, Autoimmune Rheumatic Disease, and Anti–Tumor Necrosis Factor Therapy, Europe
Emerging Infectious Diseases, 05/29/09
Xynos ID et al. - The authors report 2 new cases of leishmaniasis involving patients with autoimmune rheumatic diseases who received anti–tumor necrosis factor (anti-TNF) agents. They also reviewed all similar cases from Europe reported in the literature, and they discuss the implications of leishmaniasis in the setting of anti-TNF therapy, which is associated with increased risk for opportunistic infections.
Related Articles
Protein-energy malnutrition as a risk factor for visceral leishmaniasis: a review
Parasite Immunology, 10/26/09
Relevance Score: 85%
Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent
Tropical Medicine & International Health, 11/17/09
Relevance Score: 84%
Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
Clinical and Experimental Dermatology, 11/17/09
Relevance Score: 84%
Leishmaniasis presenting to the otolaryngologist: a rare but important cause of persistent hoarseness
The Journal of Laryngology & Otology, 10/08/09
Relevance Score: 83%
Foxp3 expression in lesions of the different clinical forms of American tegumentary leishmaniasis
Parasite Immunology, 10/27/09
Relevance Score: 82%
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Echocardiography as an Outcome Measure in Scleroderma-related Pulmonary Arterial Hypertension: Results of a Systematic Literature Analysis by the EPOSS Group
Journal of Rheumatology, 12/08/09
Depletion of functionally active CD20+ T cells by rituximab treatment
Arthritis & Rheumatism, 12/07/09
Sponsor
Article Search
Sponsor


See Latest Articles


